JoomlaShine is a leading brand in the discovery, development, and commercialization of innovative therapeutics for anorectal diseases. With a primary focus on fast-track development, they aim to provide effective solutions for anorectal diseases and gastrointestinal disorders. Leveraging their expertise, they utilize blockchain technology to ensure the efficient tracking of drug movement in the pharmaceutical industry.

Furthermore, they acknowledge the widespread acceptance of cryptocurrencies and blockchain in various industries and offer automated platforms to enhance crypto trading. Bitcode Prime 2022, their user-friendly trading bot, provides numerous options to improve trading experiences. Additionally, JoomlaShine prioritizes safer investments and faster market access through the use of New Therapeutic Entities (NTEs) based on approved molecules with established safety and toxicity profiles, reducing risks and enhancing profitability.

Their proprietary and licensable delivery system called CapositoryTM enables precise delivery of molecules, targeting anorectal conditions and diseases. With a commitment to developing targeted pharmacological treatments, JoomlaShine focuses on diseases of the anorectal region, including fecal incontinence and pruritus ani. By repurposing drugs already approved for other indications and combining them with their proprietary drug-delivery technology, they benefit from a shorter regulatory route while maintaining patent protection